New Strategies in the Discovery of Novel Non-Camptothecin Topoisomerase I Inhibitors

E-ISSN： 1875-533x|18|28|4389-4409

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.18, Iss.28, 2011-10, pp. : 4389-4409

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Non-Camptothecin DNA Topoisomerase I Inhibitors in Cancer Therapy

Current Topics in Medicinal Chemistry, Vol. 3, Iss. 3, 2003-01 ,pp. : 305-320

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting DNA Topoisomerase I with Non-Camptothecin Poisons

Current Medicinal Chemistry, Vol. 19, Iss. 8, 2012-03 ,pp. : 1238-1257

Bentham Science Publishers

Access to resources Recommend Favorite

Strategies Targeting DNA Topoisomerase I in Cancer Chemotherapy: Camptothecins, Nanocarriers for Camptothecins, Organic Non-Camptothecin Compounds and Metal Complexes

Current Drug Targets, Vol. 17, Iss. 16, 2016-12 ,pp. : 1928-1939

Bentham Science Publishers

Access to resources Recommend Favorite

Novel camptothecin derivatives as topoisomerase I inhibitors

By Basili Serena Moro Stefano

Expert Opinion on Therapeutic Patents, Vol. 19, Iss. 5, 2009-05 ,pp. : 555-574

Informa Healthcare

Access to resources Recommend Favorite

Non-camptothecin topoisomerase I active compounds as potential anticancer agents

By Long B.H. Balasubramanian B.N.

Expert Opinion on Therapeutic Patents, Vol. 10, Iss. 5, 2000-05 ,pp. : 635-666

Informa Healthcare

Access to resources Recommend Favorite